Literature DB >> 15165704

Increased IL-1beta in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase.

F O Maher1, D S D Martin, M A Lynch.   

Abstract

Ageing is accompanied by a myriad of changes, which lead to deficits in synaptic function and recent studies have identified an increase in concentration of the proinflammatory cytokine, interleukin-1beta (IL-1beta), as a factor which significantly contributes to deterioration of cell function. Here, we consider that increased IL-1beta concentration and upregulation of IL-1beta-induced cell signalling cascades may be accompanied by downregulation of survival signals, perhaps as a consequence of decreased neurotrophins-associated signalling. The data indicate that increased IL-1beta concentration was coupled with downregulation of ERK and phosphoinositide-3 kinase (PI-3 kinase) in cortical tissue prepared from aged rats. These changes could not be attributed to decreased concentration of NGF or BDNF but the evidence suggested that they may be a consequence of an age-related change in the anti-inflammatory cytokine, IL-4. Significantly, treatment of aged rats with eicosapentaenoic acid reversed the age-related increases in IL-1beta and IL-1beta-induced signalling and also the age-related changes in IL-4, ERK and PI-3 kinase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165704     DOI: 10.1016/j.neurobiolaging.2003.08.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

Review 1.  Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences.

Authors:  Elissa J Donzis; Natalie C Tronson
Journal:  Neurobiol Learn Mem       Date:  2014-08-21       Impact factor: 2.877

Review 2.  The brain, sirtuins, and ageing.

Authors:  Akiko Satoh; Shin-Ichiro Imai; Leonard Guarente
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 3.  Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

4.  Dexamethasone Induces a Specific Form of Ramified Dysfunctional Microglia.

Authors:  Min-Jung Park; Hyun-Sun Park; Min-Jung You; Jongman Yoo; Seung Hyun Kim; Min-Soo Kwon
Journal:  Mol Neurobiol       Date:  2018-06-09       Impact factor: 5.590

Review 5.  Microglia Priming with Aging and Stress.

Authors:  Anzela Niraula; John F Sheridan; Jonathan P Godbout
Journal:  Neuropsychopharmacology       Date:  2016-09-08       Impact factor: 7.853

6.  Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.

Authors:  Roger Hudson; Justine Renard; Christopher Norris; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2019-09-30       Impact factor: 6.167

7.  Immune and behavioral consequences of microglial reactivity in the aged brain.

Authors:  Angela M Wynne; Christopher J Henry; Jonathan P Godbout
Journal:  Integr Comp Biol       Date:  2009-04-23       Impact factor: 3.326

Review 8.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

9.  Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines.

Authors:  Christopher J Henry; Yan Huang; Angela M Wynne; Jonathan P Godbout
Journal:  Brain Behav Immun       Date:  2008-09-12       Impact factor: 7.217

10.  Age decreases macrophage IL-10 expression: Implications for functional recovery and tissue repair in spinal cord injury.

Authors:  Bei Zhang; William M Bailey; Kaitlyn J Braun; John C Gensel
Journal:  Exp Neurol       Date:  2015-08-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.